Click a link below to view the mailing archive as if it had been sent to you.
| 2017-07-31 12:15 | | Jurors could begin deliberations in 'Pharma Bro' Shkreli's fraud trial and more... |
| 2017-07-30 12:15 | | Court Ruling on 'Biosimilars' Sets Stage for More Drug Acquisitions and more... |
| 2017-07-29 12:15 | | Alexion leaves Moderna, others behind in R&D shake-up and more... |
| 2017-07-29 00:15 | | Pharma Bro Shkreli Decision Not To Testify In His Own Defense Was No Surprise and more... |
| 2017-07-28 12:15 | | McCain’s ‘no’ vote kills ‘skinny repeal’ in early morning drama on Capitol Hill and more... |
| 2017-07-28 00:15 | | A humbling setback for an immune-revving cancer therapy underscores the many questions facing the field and more... |
| 2017-07-27 12:15 | | AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment and more... |
| 2017-07-27 00:15 | | With $39B in cash and biosim threats looming, could Amgen use a deal? Executives say not yet and more... |
| 2017-07-26 12:15 | | These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now and more... |
| 2017-07-25 12:15 | | Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities and more... |
| 2017-07-25 00:15 | | Study: Medical device trials still ignoring gender, age, race and more... |
| 2017-07-24 12:15 | | Drug spending in U.S. tops the world. Translation: No pricing-headache relief soon and more... |
| 2017-07-23 12:15 | | 5 Things You Probably Didn't Know About Pfizer Inc. and more... |
| 2017-07-23 00:15 | | Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment and more... |
| 2017-07-22 12:15 | | Drugmakers face challenges marketing new heart drugs and more... |
| 2017-07-22 00:15 | | With Viagra and Lyrica fading, analysts downgrade Pfizer due to mounting challenges and more... |
| 2017-07-21 12:15 | | AstraZeneca CEO reassures staff, aims to be at September cancer meet and more... |
| 2017-07-21 00:15 | | Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK and more... |
| 2017-07-20 12:15 | | Sanofi offers Ablynx billions of biobucks for nanobody partnership and more... |
| 2017-07-20 00:15 | | How AbbVie Could Hammer Gilead's Hepatitis C Franchise and more... |
| 2017-07-19 12:15 | | Biotech M&A? Novartis chief Jimenez says he’s sticking to the under-$1B aisle for now and more... |
| 2017-07-19 00:15 | | 'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis and more... |
| 2017-07-18 12:15 | | Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report and more... |
| 2017-07-18 00:15 | | This Secretive Clan Wants to Beat the World’s Biggest Drugmakers and more... |
| 2017-07-17 12:15 | | 3 Small Biotech Stocks Being Run by Proven Winners and more... |
| 2017-07-17 00:15 | | Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter and more... |
| 2017-07-15 12:15 | | From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives and more... |
| 2017-07-15 00:15 | | Will he stay or will he go? AZ's shares jump, Teva's sink on report that Soriot will stay put |
| 2017-07-14 12:15 | | Insurance giant takes Insys to court for 'creative, fraudulent, and illegal' opioid promotion scheme and more... |
| 2017-07-14 00:15 | | Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says and more... |
| 2017-07-13 12:15 | | 5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings and more... |
| 2017-07-13 00:15 | | Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med and more... |
| 2017-07-12 12:15 | | D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T and more... |
| 2017-07-12 00:15 | | HPV Infection Rates Plummet With Vaccination and more... |
| 2017-07-11 12:15 | | Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend and more... |
| 2017-07-11 00:15 | | These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now and more... |
| 2017-07-10 12:15 | | How Reproducible are Preclinical Study Results? and more... |
| 2017-07-10 00:15 | | What the FDA's Hold on Three Merck Studies Means for Other Drug Makers and more... |
| 2017-07-09 12:15 | | How Shrewd of a Dealmaker Is Gilead Sciences? Just Look at Its Last 7 Acquisitions and more... |
| 2017-07-09 00:15 | | Will Johnson & Johnson's Dividend Keep Climbing? |
| 2017-07-08 12:15 | | Capillary Biomedical takes aim at ‘the Achilles heel of diabetes’ and more... |
| 2017-07-08 00:15 | | J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it and more... |
| 2017-07-07 12:15 | | Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin and more... |
| 2017-07-07 00:15 | | Amgen, Teva hikes show pharma can't blame rebates for all price increases: analyst and more... |
| 2017-07-06 12:15 | | Ex-AstraZeneca executive Luke Miels accuses CEO Soriot of threatening him for taking GSK job and more... |
| 2017-07-06 00:15 | | Industry paid $8.2B to docs, hospitals last year and more... |
| 2017-07-05 12:15 | | Shire will cut U.S. locations and move HQ in consolidation push and more... |
| 2017-07-05 00:15 | | Martin Shkreli's lawyer objects to gag order, blames media and client's 'frail emotional state' for courthouse rant and more... |
| 2017-07-04 00:15 | | Shkreli’s Social Media Antics Don't Slow During Fraud Trial and more... |
| 2017-07-03 12:15 | | Martin Shkreli blasts prosecutors as 'junior varsity,' says investor wasn't 'victim' and criticizes headlines in lunch visit to reporters and more... |
| 2017-07-02 12:15 | | Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit? and more... |
| 2017-07-01 12:15 | | The Importance of the Safety Management Plan for Clinical Trials and more... |
